Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
91-105 of 1528 results
Onxeo reports positive preliminary results from Validive Phase II trial for oral mucositis
By PBR Staff Writer
French biopharmaceutical firm Onxeo has reported positive preliminary top-line results from its Phase II clinical trial of Validive (mucoadhesive buccal tablet MBT clonidine Lauriad) to prevent severe oral mucositis (OM).
Automation > IT & Software > News
Protein Sciences gets FDA approval for Flublok influenza vaccine for adults aged 18 and older
By PBR Staff Writer
US-based Protein Sciences has received approval from the US Food and Drug Administration (FDA) for Flublok influenza vaccine to treat adults aged 18 years and older.
Automation > IT & Software > News
OliPass, Bristol-Myers partner for PNA-based therapeutics
By PBR Staff Writer
South Korea-based biopharmaceutical firm OliPass has entered into a strategic alliance with Bristol-Myers Squibb (BMS) to discover and develop therapeutics against multiple targets using the former's technology platform.
Automation > IT & Software > News
Amunix signs services and supply deal with University of Nebraska-Lincoln to produce GMP-Grade XTEN
Amunix Operating, a biotechnology company developing polypeptides which can be recombinantly fused or chemically conjugated to other peptides, proteins and small molecules, has entered into a Services and Supply Agreement with the University of Nebraska-Lincoln Biological Process Development Facility to provide kilogram-scale, GMP-Grade XTEN for chemical conjugation.
Automation > IT & Software > News
Zymeworks, Lilly extend deal for new bi-specific immunotherapies on Azymetric platform
By PBR Staff Writer
Zymeworks and Eli Lilly and Company have extended their existing licensing and collaboration agreement for development of an undisclosed number of new bi-specific antibody therapeutics using the former’s Azymetric platform.
Automation > IT & Software > News
Certara gets FDA grant to improve Simcyp's MechDermA to permit drug bioequivalence assessment
Certara, the leading global technology-enabled drug development and drug safety consultancy, has received a Food and Drug Administration (FDA) Office of Generic Drugs grant (#1 U01 FD005225-01) to further develop and validate its Simcyp Simulator’s mechanistic dermal absorption model, MechDermA.
Automation > IT & Software > News
iBio expands exclusive product collaboration with Novici Biotech
iBio, a provider of plant-based biotechnology for developing and manufacturing biological products, and Novici Biotech (Novici) have agreed to broaden their commercial collaboration, currently focused on antibodies and certain vaccine products, to include iBio's proprietary IBIO-CFB03 product for idiopathic pulmonary fibrosis, systemic sclerosis and other fibrotic diseases.
Automation > IT & Software > News
Plandai Biotechnology's technology could prove potent in battling alzheimers disease
In the recently released preliminary results from Plandaí Biotechnology's human clinical trial that compared its green tea extract to a commercially available extract, Professor Anne Grobler and her team at North West University in South Africa proved that all 8 catechins found in the green tea plant were absorbed into the bloodstream of those using Phytofare Catechin Complex, including, the most potent catechin of the eight, epigallocatechin-3-gallate or EGCG.
Automation > IT & Software > News
MedImmune’s Phase I OX40 agonist trial uses AgonOx’s OX40 platform
By PBR Staff Writer
US-based biotechnology firm AgonOx has announced that its OX40 platform is being used in AstraZeneca's global biologics research and development arm MedImmune’s Phase I trial of its humanized OX40 agonist, MEDI6383.
Automation > IT & Software > News
Aduro expands deal with Janssen to develop product candidates for lung cancer
By PBR Staff Writer
Aduro BioTech has entered into its second agreement with Janssen Biotech, granting an exclusive, worldwide license to certain product candidates designed to treat lung cancer and certain other cancers based on its novel LADD immunotherapy platform.
Automation > IT & Software > News
Immune Design, Sanofi Pasteur to develop herpes simplex virus therapy
By PBR Staff Writer
US-based clinical-stage immunotherapy firm Immune Design and Sanofi Pasteur have entered into a collaboration to develop a herpes simplex virus (HSV) immune therapy.
Automation > IT & Software > News
Nuvilex gets worldwide license for insulin-producing cells from University of Technology for use in developing diabetes treatment
Nuvilex has entered into a license with the University of Technology in Sydney, Australia (UTS), that grants Nuvilex the worldwide rights to use human insulin-producing cells, termed "Melligen" cells, developed by Prof. Ann Simpson and her colleagues at UTS for the development of a treatment for insulin-dependent (Type 1 or juvenile-onset) diabetes.
Automation > IT & Software > News
MorphoSys acquires Lanthio's lanthipeptide technology
By PBR Staff Writer
MorphoSys has exercised an option with Lanthio Pharma to acquire its lanthipeptide technology for drug discovery.
Automation > IT & Software > News
Orgenesis receives patent for potential cure for type 1 diabetes
Orgenesis, a leader in the emerging fields of cellular therapy and regenerative medicine, has announced that it has received a patent for the technology supporting its unique cell-based therapy, which is being developed as a potential cure for Type 1 Diabetes.
Automation > IT & Software > News
Portal Instruments completes landmark $11m series A financing for new drug delivery platform
Portal Instruments, a new dynamic, emerging leader in the development of innovative drug delivery systems, has completed a landmark $11m Series A financing led by Sanofi through its Sunrise initiative along with PBJ Capital (a Boston-based venture firm) and a major US medical device company.
Automation > IT & Software > News
91-105 of 1528 results